PL3325081T3 - Sposoby dostarczania limfatycznego środków czynnych - Google Patents
Sposoby dostarczania limfatycznego środków czynnychInfo
- Publication number
- PL3325081T3 PL3325081T3 PL16831144T PL16831144T PL3325081T3 PL 3325081 T3 PL3325081 T3 PL 3325081T3 PL 16831144 T PL16831144 T PL 16831144T PL 16831144 T PL16831144 T PL 16831144T PL 3325081 T3 PL3325081 T3 PL 3325081T3
- Authority
- PL
- Poland
- Prior art keywords
- methods
- active agents
- lymphatic delivery
- lymphatic
- delivery
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title 1
- 230000001926 lymphatic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0023—Drug applicators using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/003—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a lumen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0061—Methods for using microneedles
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Medical Informatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562196558P | 2015-07-24 | 2015-07-24 | |
US201562196568P | 2015-07-24 | 2015-07-24 | |
EP16831144.7A EP3325081B1 (en) | 2015-07-24 | 2016-07-22 | Methods for lymphatic delivery of active agents |
PCT/US2016/043656 WO2017019535A2 (en) | 2015-07-24 | 2016-07-22 | Methods for lymphatic delivery of active agents |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3325081T3 true PL3325081T3 (pl) | 2021-12-20 |
Family
ID=57885089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL16831144T PL3325081T3 (pl) | 2015-07-24 | 2016-07-22 | Sposoby dostarczania limfatycznego środków czynnych |
Country Status (15)
Country | Link |
---|---|
US (3) | US10737082B2 (pl) |
EP (2) | EP3922238A1 (pl) |
JP (3) | JP6929829B2 (pl) |
KR (1) | KR20180035210A (pl) |
CN (1) | CN107949418B (pl) |
AU (3) | AU2016297832B2 (pl) |
BR (1) | BR112018001435A2 (pl) |
CA (1) | CA2991459A1 (pl) |
DK (1) | DK3325081T3 (pl) |
ES (1) | ES2893673T3 (pl) |
HU (1) | HUE056424T2 (pl) |
MX (2) | MX2018000126A (pl) |
PL (1) | PL3325081T3 (pl) |
RU (1) | RU2719946C2 (pl) |
WO (1) | WO2017019535A2 (pl) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017019535A2 (en) * | 2015-07-24 | 2017-02-02 | Kimberly-Clark Worldwide, Inc. | Methods for lymphatic delivery of active agents |
EP3925599A1 (en) * | 2015-07-24 | 2021-12-22 | Sorrento Therapeutics, Inc. | Methods for better delivery of active agents to tumors |
EP3677283A4 (en) * | 2017-08-31 | 2021-05-12 | Tohoku University | APPROPRIATE AREA OF OSMOTIC PRESSURE OF A SOLUTION WITH MEDICINAL PRODUCT EFFECTIVE IN LYMPHODIC DELIVERY SYSTEM |
WO2021113585A1 (en) | 2019-12-05 | 2021-06-10 | Sorrento Therapeutics, Inc. | Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic delivery device |
JP7509402B2 (ja) | 2020-02-26 | 2024-07-02 | 国立大学法人 和歌山大学 | 解析装置、センシングシステム、解析装置の動作方法、及び、コンピュータプログラム |
CN117813128A (zh) | 2021-01-22 | 2024-04-02 | 索伦托药业有限公司 | 用于微升级淋巴递送冠状病毒疫苗的装置 |
WO2022192594A2 (en) | 2021-03-11 | 2022-09-15 | Sorrento Therapeutics, Inc. | Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease |
WO2022261262A1 (en) | 2021-06-09 | 2022-12-15 | Sorrento Therapeutics, Inc. | Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic microneedle delivery device |
CN113368385A (zh) * | 2021-06-21 | 2021-09-10 | 温州医科大学慈溪生物医药研究院 | 利用淋巴通路递送生物大分子药物入脑的输送系统 |
CA3228858A1 (en) | 2021-08-18 | 2023-02-23 | Russell F. Ross | Therapeutic agents targeting the lymphatic system |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE72524B1 (en) | 1994-11-04 | 1997-04-23 | Elan Med Tech | Analyte-controlled liquid delivery device and analyte monitor |
US6503231B1 (en) * | 1998-06-10 | 2003-01-07 | Georgia Tech Research Corporation | Microneedle device for transport of molecules across tissue |
US20020095134A1 (en) * | 1999-10-14 | 2002-07-18 | Pettis Ronald J. | Method for altering drug pharmacokinetics based on medical delivery platform |
DE60101206T2 (de) * | 2000-06-01 | 2004-09-02 | Watson Pharmaceuticals, Inc., Corona | Transdermale verabreichung von lasofoxifen |
CA2460063C (en) * | 2001-09-12 | 2010-07-20 | Becton, Dickinson And Company | Microneedle-based pen device for drug delivery and method for using same |
WO2004064889A2 (en) * | 2003-01-16 | 2004-08-05 | Becton, Dickinson And Company | Intradermal cellular delivery using narrow gauge micro-cannula |
CA2529048A1 (en) * | 2003-06-13 | 2005-02-24 | Becton, Dickinson And Company | Improved intra-dermal delivery of biologically active agents |
CA2536669A1 (en) | 2003-08-26 | 2005-03-17 | Becton, Dickinson And Company | Methods for intradermal delivery of therapeutics agents |
WO2006127962A2 (en) * | 2005-05-25 | 2006-11-30 | Becton, Dickinson And Comapny | Particulate formulations for intradermal delivery of biologically active agents |
CN101287507B (zh) | 2005-08-12 | 2012-12-05 | 刘江 | 用于淋巴靶向的方法和装置 |
US20070087029A1 (en) | 2005-10-14 | 2007-04-19 | Pakala Syamasundar V | Localized delivery to the lymphatic system |
US8197435B2 (en) * | 2006-05-02 | 2012-06-12 | Emory University | Methods and devices for drug delivery to ocular tissue using microneedle |
EP2029106A2 (en) | 2006-06-07 | 2009-03-04 | Foamix Ltd. | Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof |
EP2100850A1 (en) * | 2008-03-11 | 2009-09-16 | Stichting Voor De Technische Wetenschappen | Microneedle array and a method for manufacturing microneedles |
US8568363B2 (en) * | 2008-10-31 | 2013-10-29 | The Invention Science Fund I, Llc | Frozen compositions and methods for piercing a substrate |
PT2563453T (pt) * | 2010-04-28 | 2017-03-15 | Kimberly Clark Co | Dispositivo medicinal possuindo uma nanoforma com melhor interacção celular e um método para a sua formação |
WO2011135531A2 (en) | 2010-04-28 | 2011-11-03 | Kimberly-Clark Worldwide, Inc. | MEDICAL DEVICES FOR DELIVERY OF siRNA |
WO2012046149A1 (en) * | 2010-04-28 | 2012-04-12 | Kimberly-Clark Worldwide, Inc. | Method for increasing permeability of an epithelial barrier |
JP5860032B2 (ja) * | 2010-04-28 | 2016-02-16 | キンバリー クラーク ワールドワイド インコーポレイテッド | 関節リウマチ薬の送達のためのデバイス |
US20120187814A1 (en) | 2011-01-25 | 2012-07-26 | Fryling Nicholas A | Furniture System and a Frame Assembly for a Furniture System |
US20120245445A1 (en) * | 2011-03-21 | 2012-09-27 | Michael Darryl Black | Glucose Monitoring System |
RS59898B1 (sr) * | 2011-10-17 | 2020-03-31 | Massachusetts Inst Technology | Intraćelijsko davanje |
KR102265775B1 (ko) | 2011-10-27 | 2021-06-16 | 소렌토 쎄라퓨틱스, 인코포레이티드 | 고점도 생체활성 제제의 경피 전달 방법 |
US20170246439A9 (en) * | 2011-10-27 | 2017-08-31 | Kimberly-Clark Worldwide, Inc. | Increased Bioavailability of Transdermally Delivered Agents |
CN104703651A (zh) * | 2012-05-01 | 2015-06-10 | 高等教育联邦系统-匹兹堡大学 | 用于经皮插入的尖端负载的微针阵列 |
AU2014222308B2 (en) | 2013-02-28 | 2018-11-08 | Vivasor, Inc. | Transdermal drug delivery device |
US9861801B2 (en) | 2013-02-28 | 2018-01-09 | Kimberly-Clark Worldwide, Inc. | Drug delivery device |
EP2999510A1 (en) | 2013-05-23 | 2016-03-30 | Kimberly-Clark Worldwide, Inc. | Microneedles with improved open channel cross-sectional geometries |
EP3925599A1 (en) * | 2015-07-24 | 2021-12-22 | Sorrento Therapeutics, Inc. | Methods for better delivery of active agents to tumors |
WO2017019535A2 (en) * | 2015-07-24 | 2017-02-02 | Kimberly-Clark Worldwide, Inc. | Methods for lymphatic delivery of active agents |
-
2016
- 2016-07-22 WO PCT/US2016/043656 patent/WO2017019535A2/en active Application Filing
- 2016-07-22 EP EP21189701.2A patent/EP3922238A1/en active Pending
- 2016-07-22 PL PL16831144T patent/PL3325081T3/pl unknown
- 2016-07-22 BR BR112018001435A patent/BR112018001435A2/pt not_active Application Discontinuation
- 2016-07-22 CN CN201680050966.3A patent/CN107949418B/zh active Active
- 2016-07-22 HU HUE16831144A patent/HUE056424T2/hu unknown
- 2016-07-22 AU AU2016297832A patent/AU2016297832B2/en active Active
- 2016-07-22 MX MX2018000126A patent/MX2018000126A/es unknown
- 2016-07-22 KR KR1020187003327A patent/KR20180035210A/ko not_active Application Discontinuation
- 2016-07-22 JP JP2018500418A patent/JP6929829B2/ja active Active
- 2016-07-22 RU RU2018104104A patent/RU2719946C2/ru active
- 2016-07-22 ES ES16831144T patent/ES2893673T3/es active Active
- 2016-07-22 US US15/744,385 patent/US10737082B2/en active Active
- 2016-07-22 CA CA2991459A patent/CA2991459A1/en active Pending
- 2016-07-22 EP EP16831144.7A patent/EP3325081B1/en active Active
- 2016-07-22 DK DK16831144.7T patent/DK3325081T3/da active
-
2018
- 2018-01-08 MX MX2022014634A patent/MX2022014634A/es unknown
-
2020
- 2020-07-10 US US16/925,548 patent/US20200338329A1/en not_active Abandoned
- 2020-09-18 AU AU2020233748A patent/AU2020233748B2/en active Active
-
2021
- 2021-08-11 JP JP2021131298A patent/JP7167272B2/ja active Active
-
2022
- 2022-10-26 JP JP2022171479A patent/JP2023015135A/ja not_active Withdrawn
- 2022-11-21 AU AU2022275393A patent/AU2022275393A1/en active Pending
-
2024
- 2024-02-15 US US18/442,568 patent/US20240181235A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US10737082B2 (en) | 2020-08-11 |
AU2016297832A1 (en) | 2018-02-15 |
AU2022275393A1 (en) | 2023-01-05 |
JP6929829B2 (ja) | 2021-09-01 |
ES2893673T3 (es) | 2022-02-09 |
RU2719946C2 (ru) | 2020-04-23 |
CA2991459A1 (en) | 2017-02-02 |
US20240181235A1 (en) | 2024-06-06 |
JP2018522002A (ja) | 2018-08-09 |
MX2022014634A (es) | 2023-01-18 |
EP3325081A2 (en) | 2018-05-30 |
KR20180035210A (ko) | 2018-04-05 |
WO2017019535A2 (en) | 2017-02-02 |
EP3325081A4 (en) | 2019-04-10 |
CN107949418B (zh) | 2024-07-02 |
RU2018104104A3 (pl) | 2019-10-31 |
RU2018104104A (ru) | 2019-08-26 |
US20200338329A1 (en) | 2020-10-29 |
EP3922238A1 (en) | 2021-12-15 |
JP2023015135A (ja) | 2023-01-31 |
JP7167272B2 (ja) | 2022-11-08 |
BR112018001435A2 (pt) | 2018-09-11 |
AU2016297832B2 (en) | 2020-07-16 |
MX2018000126A (es) | 2018-03-23 |
HUE056424T2 (hu) | 2022-02-28 |
US20180193625A1 (en) | 2018-07-12 |
EP3325081B1 (en) | 2021-09-08 |
CN107949418A (zh) | 2018-04-20 |
AU2020233748B2 (en) | 2022-08-25 |
AU2020233748A1 (en) | 2020-10-08 |
JP2021185160A (ja) | 2021-12-09 |
DK3325081T3 (da) | 2021-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1256383A1 (zh) | 治療劑 | |
IL249837B (en) | An inhaler for administering active substances through the lungs | |
PT3386484T (pt) | Composições e métodos para entrega de agentes terapêuticos | |
PL3325081T3 (pl) | Sposoby dostarczania limfatycznego środków czynnych | |
GB201701039D0 (en) | Vertically integrated continuous delivery of an application | |
IL241064A0 (en) | An array with a microstructure for the introduction of active substances | |
ZA201903467B (en) | Transdermal delivery of large agents | |
GB201509893D0 (en) | Therapeutic agents | |
IL249455A0 (en) | Complexes of mineral-amino acids with active substances | |
HUE056410T2 (hu) | Eljárások a hatóanyagok jobb bejuttatására a tumorokba | |
GB201517263D0 (en) | Therapeutic agents | |
GB201410816D0 (en) | Therapeutic agents | |
EP3405151A4 (en) | IMPROVED TRANSDERMAL DISTRIBUTION OF ACTIVE SUBSTANCES | |
GB201509885D0 (en) | Therapeutic agents | |
GB201410815D0 (en) | Therapeutic agents | |
GB201410817D0 (en) | Therapeutic agents | |
HK1245639A1 (zh) | 纖維化病治療劑 | |
GB201509888D0 (en) | Therapeutic agents | |
ZA201800163B (en) | New anti-malarial agents | |
EP3094347A4 (en) | Methods for enhancing the delivery of active agents | |
GB201513299D0 (en) | Therapeutic agents | |
GB201410507D0 (en) | Drug delivery enhancement agents | |
GB201521767D0 (en) | Therapeutic agents | |
GB201409653D0 (en) | Pyrrolobenzodiazepine therapeutic agents | |
GB201517264D0 (en) | Therapeutic agents |